PROTECTORIAL/PURO PROTECT - Isotonic ointment with Hyaluronic Acid 0.4% (Ophthalmology - Dry Eye)

PROTECTORIAL/PURO PROTECT - Isotonic ointment with Hyaluronic Acid 0.4% (Ophthalmology - Dry Eye)
Product Description

First in class ointment in the market enriched with Hyaluronic Acid. This product, thanks to Hyaluronic Acid and its isotonic characteristic, has been specifically formulated to offer effective symptoms relief for patients suffering from moderate to severe dry eye, kerato-conjunctivitis sicca and nocturnal lagophthalmos; it protects the ocular surface, it improves the tear film stability and it helps the healing process of the damaged corneal epithelium. It is recommended for night time use.

- Presentation: Tube 10gr - Class: Medical Device IIa
- CE Mark expiry date: 2024

-        2 scientific publications available


NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)
Specifications
  • Selling Points
    Product Performance
  • Supplied from
    Italy

NTC S.r.l.

  • IT
  • 2015
    On CPHI since
  • 3
    Certificates
  • 100 - 249
    Employees
Company types
Pharmaceutical company
Primary activities
Pharmaceutical Company (innovator finished products)

More Products from NTC S.r.l. (29)

NTC S.r.l. resources (1)

  • Brochure Therapeutical areas - brochure

    Advanced scientific research and technology drive our efforts to innovate care practices.
    Our range of products builds from our historical vocation for innovation aimed at improving the experience of patients and healthcare practices.
    An innovation aimed at discovering specific therapeutic gestures: simple and intuitive,  sustainable, and technically advanced for empowering the patient.
    Our research aims to put pioneering new products within the reach of everyone and to optimize the
    performance of our products by analyzing the daily needs and habits of people undergoing treatment.
    We research, develop and produce innovative drugs, medical devices and food supplements.
    We market our products worldwide through licensing, distribution, marketing, and commercial deals with partner companies.
    Our core therapeutic areas are: Ophthalmology, Gastro-Metabolism, Pediatrics and Gynacology.